US Patent Issued to Disc Medicine, Abb Vie, AbbVie Deutschland on Aug. 25 for "Methods of using anti-hemojuvelin (HJV) antibodies for treating myelofibrosis" (American, German Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,917, issued on Aug. 25, was assigned to Disc Medicine Inc. (Watertown, Mass.), Abb Vie Inc. (North Chicago, Ill.) and AbbVie Deutschland Gmbh & Co. KG (Wiesbaden, Germany).

"Methods of using anti-hemojuvelin (HJV) antibodies for treating myelofibrosis" was invented by Maria Beconi (Cambridge, Mass.), John Quisel (Cambridge, Mass.), Brian MacDonald (Bend, Ore.), Steven Robinette (Fremont, N.H.), Bernhard Mueller (Hannover, Germany), Andreas Popp (Sprockhovel, Germany) and Jennifer M. Perez (Worcester, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Aspects of the application provide anti-hemojuvelin antibodies and methods of using the same in tr...